Detox Products Market Analysis Highlights the Impact of COVID-19 (2020-2030) | Launch Of Innovative Products to Boost Market Growth
Detox products are used to clean blood, aesthetics and internal organs through elimination of harmful toxins. Changing lifestyle, deterioration of environment, and expanding drug addict population have resulted in creating a demand for detox products globally. The Global Detox Products market was valued at US$ 48 billion in 2019. Prolonged exposure to certain medicines such as opioids results in addiction and involuntary requirement, thereby exposing internal organs to severe side effects. Increasing number of drug rehabilitation centres, increasing awareness regarding detox products, and WHO initiatives are the major factors fuelling the growth of the global detox product market.
Get a PDF Sample Report (including COVID-19 impact analysis): https://www.insightslice.com/request-sample/487
The demand for detox products from health enthusiasts has increased over past few years fuelled by spreading awareness and easy availability of detox products. The herbal detox products are available for over the counter purchase, as contrary to the pharmaceutical detox products. This has fuelled the demand for herbal detox products across the globe. The global detox product market is expected to expand at a prominent growth rate during the forecast period.
Pharmaceutical detox products experience increased demand as compared to other types
The global detox products market is segmented on the basis of product type, and geography. Based on product type, the global detox products market is segmented into pharmaceutical detox products, herbal detox products, and cosmetic detox products. The pharmaceutical detox product segment contributed a dominating share to the global detox product market in 2019 and is anticipated to grow significantly during the forecast period. The pharmaceutical detox products such as methadone are primarily used for detoxification of opioids and are available as a prescribed drug across major countries globally. Strong prevalence of opioid addiction and rising awareness regarding detox products is anticipated to contribute towards the growth of pharmaceutical detox product in coming years.
Purchase Complete Report at Discounted Price: https://www.insightslice.com/request-discount/487
The herbal detox products are gaining popularity across the globe and are expected to witness significant growth during the forecast period. Rising demand for dietary detox products such as green tea fuelled by growing health awareness and availability of wide products at affordable price is fuelling the demand for herbal detox products globally. The demand for cosmetic detox products is increasing significantly for skin purification and cleansing applications, which are expected to contribute a prominent share to the global detox products market in coming years.
Based on geography, the global detox products market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America contributed largest share to the global detox products market in 2019 and is expected to witness steady growth during forecast period. The number of drug addicts across The United States has increased significantly during past decade due to availability of drugs and exposure to addictive medications such as opioids. To tackle the increasing number of drug addict population, the United States health authorities have worked in establishment of rehabilitation centres across the country, thereby fuelling the demand for detox products. Asia Pacific is anticipated to witness prominent growth during the forecast period owing to increasing number or drug addicts and rising health awareness across the major countries.
Major players active in the global detox products market include Biodelivery Sciences International Inc., Body Ecology, Inc., Daiichi Pharmaceutical Co., Detoxify LLC., Himalaya Global Holdings Ltd., Mallinckrodt PLC., Mylan N.V., Novartis AG., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., The Bioforce Group, Valeant Pharmaceuticals International, Inc. and West-Ward Pharmaceuticals Corp.